Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction

In this meta-analysis including individual-patient data from five randomized trials, beta-blocker therapy did not reduce the incidence of death from any cause, myocardial infarction, or heart failure in patients with an LVEF of at least 50% after myocardial infarction without other indications for beta-blockers. (Funded by Centro Nacional de Investigaciones Cardiovasculares Carlos III and others; PROSPERO database number, CRD420251119176.).

Authors

Institutions

Publication Details

Journal
New England Journal of Medicine
Published
2025-11-09
DOI
https://doi.org/10.1056/nejmoa2512686
Citations
15
Primary Topic
Acute Myocardial Infarction Research
Type
article
Field-Weighted Citation Impact
20.82
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction

Arnhild Bakken, Therese Lucia Friis Holmager, Morten Wang Fagerland, Michael Mæng et al.
15 citations
New England Journal of Medicine
Acute Myocardial Infarction Research
20.82
article

Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction

Arnhild Bakken, Therese Lucia Friis Holmager, Morten Wang Fagerland, Michael Mæng, José A. Barrabés, Takeshi Kimura, Anna Meta Dyrvig Kristensen, Stuart Pocock, Borja Ibáñez, Roberto Latini, Kjell Vikenes, Sergio Raposeiras‐Roubín, Tomas Jernberg, Patric Karlström, Robin Hofmann, Xavier Rosselló, Michael Hecht Olsen, Bertil Lindahl, Theis Lange, Jocelyne Benatar, Valentı́n Fuster, Troels Yndigegn, David Erlinge, Neiko Ozasa, Massimo Piepoli, Claes Held, Eva Prescott, John Munkhaugen, Dan Atar
article en
15 citations

Abstract

In this meta-analysis including individual-patient data from five randomized trials, beta-blocker therapy did not reduce the incidence of death from any cause, myocardial infarction, or heart failure in patients with an LVEF of at least 50% after myocardial infarction without other indications for beta-blockers. (Funded by Centro Nacional de Investigaciones Cardiovasculares Carlos III and others; PROSPERO database number, CRD420251119176.).

New England Journal of MedicineVol. 394(6)
Uppsala University (SE), University of Copenhagen (DK), Oslo University Hospital (NO), University of Oslo (NO), Lund University (SE), University of Milan (IT), Mario Negri Institute for Pharmacological Research (IT), Aarhus University (DK), Drammen Hospital (NO), Haukeland University Hospital (NO), Frederiksberg Hospital (DK), Auckland City Hospital (NZ), Aarhus University Hospital (DK), University Hospital Complex Of Vigo (ES), Copenhagen University Hospital (DK), Copenhagen Municipal Hospital (DK), Spanish National Centre for Cardiovascular Research (ES), Karolinska Institutet (SE), London School of Hygiene & Tropical Medicine (GB), Stockholm South General Hospital (SE), IRCCS Policlinico San Donato (IT), Mount Sinai Hospital (US), Nara City Hospital (JP), Centro de Investigación Biomédica en Red (ES), Vall d'Hebron Hospital Universitari (ES), Hospital Universitario Fundación Jiménez Díaz (ES), Ryhov Hospital Jönköping (SE), Hospital Universitario Son Espases (ES), Municipal Hirakata City Hospital (JP), University of Bergen (NO), Universitat de les Illes Balears (ES), Universidad Autónoma de Madrid (ES)
Openalex Percentile: Top 0%
Acute Myocardial Infarction Research
20.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.